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Abstract
Background: Influenza is a severe contagious disease especially in children, elderly and immunocompromised
patients. Beside vaccination, the discovery of new anti-viral agents represents an important strategy to encounter
seasonal and pandemic influenza A virus (IAV) strains. The bacterial extra-cellular ribonuclease binase is a well-studied
RNase from Bacillus pumilus. Treatment with binase was shown to improve survival of laboratory animals infected with
different RNA viruses. Although binase reduced IAV titer in vitro and in vivo, the mode of action (MOA) of binase
against IAV at the molecular level has yet not been studied in depth and remains elusive.
Methods: To analyze whether binase impairs virus replication by direct interaction with the viral particle we applied a
hemagglutination inhibition assay and monitored the integrity of the viral RNA within the virus particle by RT-PCR.
Furthermore, we used Western blot and confocal microscopy analysis to study whether binase can internalize into
MDCK-II cells. By primer extension we examined the effect of binase on the integrity of viral RNAs within the cells and
using a mini-genome system we explored the effect of binase on the viral expression.
Results: We show that (i) binase does not to attack IAV particle-protected viral RNA, (ii) internalized binase could be
detected within the cytosol of MDCK-II cells and that (iii) binase impairs IAV replication by specifically degrading viral
RNA species within the infected MDCK-II cells without obvious effect on cellular mRNAs.
Conclusion: Our data provide novel evidence suggesting that binase is a potential anti-viral agent with specific
intra-cellular MOA.
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Background
Influenza A virus (IAV) is an RNA virus, which poses a
great health risk causing seasonal epidemics and periodic-
ally worldwide pandemics. Despite their seasonal charac-
ter, influenza epidemics are unpredictable and have been
recognized as a major cause of morbidity and increased
mortality [1]. Influenza virus infection leads to a disease
that results in 0.25–0.5 million deaths annually worldwide
[2]. Currently, two classes of anti-virals are available for
the treatment of seasonal human influenza: neuraminidase
inhibitors (oseltamivir, zanamivir, peramivir) and M2-
channel blockers (rimantadine and amantadine) acting on
viral spread and entry, respectively [3]. Nevertheless, vac-
cination is still the most effective preventive measure, re-
gardless to the constant changes of the viral antigenic
epitopes (antigen drift), demanding the annual renewal of
the selected vaccine strains [4, 5]. Furthermore, based on
the segmented nature of IAV genome, co-infections can
lead to reassortants with completely new antigenic charac-
teristics (antigen shift) that can cause pandemic outbreaks
[6, 7]. Thus, the efficacy of currently approved control
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